LT2419108T - Kontracepcijos pagal poreikį būdas - Google Patents

Kontracepcijos pagal poreikį būdas

Info

Publication number
LT2419108T
LT2419108T LTEP10717084.7T LT10717084T LT2419108T LT 2419108 T LT2419108 T LT 2419108T LT 10717084 T LT10717084 T LT 10717084T LT 2419108 T LT2419108 T LT 2419108T
Authority
LT
Lithuania
Prior art keywords
demand contraception
contraception
demand
Prior art date
Application number
LTEP10717084.7T
Other languages
English (en)
Inventor
André Ulmann
Erin Gainer
Diana Blithe
Lynette Nieman
Henri Camille Mathe
Original Assignee
Laboratoire Hra Pharma
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42309669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2419108(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Hra Pharma, The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical Laboratoire Hra Pharma
Publication of LT2419108T publication Critical patent/LT2419108T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
LTEP10717084.7T 2009-04-14 2010-04-13 Kontracepcijos pagal poreikį būdas LT2419108T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16914909P 2009-04-14 2009-04-14
PCT/EP2010/054812 WO2010119029A1 (en) 2009-04-14 2010-04-13 Method for on-demand contraception

Publications (1)

Publication Number Publication Date
LT2419108T true LT2419108T (lt) 2016-12-27

Family

ID=42309669

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP10717084.7T LT2419108T (lt) 2009-04-14 2010-04-13 Kontracepcijos pagal poreikį būdas

Country Status (25)

Country Link
US (4) US9616073B2 (lt)
EP (2) EP2419108B1 (lt)
JP (2) JP5951480B2 (lt)
CN (1) CN102395373A (lt)
AU (1) AU2010237120B8 (lt)
BR (1) BRPI1014035A2 (lt)
CA (1) CA2757496A1 (lt)
CY (1) CY1118236T1 (lt)
DK (1) DK2419108T3 (lt)
ES (1) ES2602134T3 (lt)
HK (1) HK1232150A1 (lt)
HR (1) HRP20161437T1 (lt)
HU (1) HUE029434T2 (lt)
IL (1) IL215524A0 (lt)
LT (1) LT2419108T (lt)
ME (1) ME02548B (lt)
NZ (2) NZ615430A (lt)
PL (1) PL2419108T3 (lt)
PT (1) PT2419108T (lt)
RS (1) RS55331B1 (lt)
RU (1) RU2542779C2 (lt)
SI (1) SI2419108T1 (lt)
SM (1) SMT201600399B (lt)
WO (1) WO2010119029A1 (lt)
ZA (1) ZA201107543B (lt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
RU2542779C2 (ru) 2009-04-14 2015-02-27 Лаборатуар Хра-Фарма Способ контрацепции, используемый по мере необходимости
WO2012121767A1 (en) * 2011-03-09 2012-09-13 Arstat, Inc. Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
CN102727457B (zh) * 2011-04-08 2014-05-28 华润紫竹药业有限公司 稳定的醋酸优力司特制剂
FR2987271B1 (fr) 2012-02-28 2017-08-18 Hra Pharma Lab Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens
JP6200493B2 (ja) 2012-09-28 2017-09-20 あすか製薬株式会社 無定形ウリプリスタール酢酸エステル
AU2013321890B2 (en) 2012-09-28 2017-05-18 Aska Pharmaceutical Co., Ltd. Crystalline polymorphic form of ulipristal acetate
JP2015532263A (ja) 2012-09-28 2015-11-09 あすか製薬株式会社 ウリプリスタール酢酸エステルの結晶多形
FR2997628B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2997627B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
SG11201503275RA (en) * 2012-11-22 2015-06-29 Bayer Pharma AG Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
FR2999081B1 (fr) 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
CN103006595B (zh) * 2012-12-25 2018-04-06 江苏亚邦爱普森药业有限公司 制备醋酸优力司特片的方法
MA38606A1 (fr) 2013-05-23 2017-03-31 Bayer Pharma AG Composition pharmaceutique et son utilisation, ainsi que schéma d'emploi de cette composition pharmaceutique pour la contraception à la demande
FR3060389B1 (fr) 2016-12-20 2019-05-31 Laboratoire Hra-Pharma Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites
WO2017216637A2 (en) 2017-08-04 2017-12-21 Alvogen Malta Operations (Row) Ltd Tablet form including ulipristal acetate and the methods for its preparation
WO2019204163A1 (en) 2018-04-20 2019-10-24 Tessenderlo Kerley, Inc. Liquid nitrogen fertilizer compositions and additives therefore
EP3575278A1 (en) 2018-05-31 2019-12-04 Tessenderlo Kerley, Inc. Liquid nitrogen fertilizer compositions and additives therefor

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6A (en) * 1836-08-10 Thomas blanghard
DE1922005A1 (de) 1969-04-24 1970-11-05 Schering Ag Mittel und Methode zur Kontrazeption
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
CN1211087C (zh) 1994-10-24 2005-07-20 舍林股份公司 用于适应需要的女性生育节制的竞争性黄体酮拮抗剂
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
WO2000003678A2 (en) * 1998-07-17 2000-01-27 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception
WO2000009136A1 (en) * 1998-08-11 2000-02-24 Akzo Nobel N.V. Progestogen-only contraceptive kit providing good cycle control
EP1605949A2 (en) 1999-08-31 2005-12-21 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
ES2546336T3 (es) * 2000-03-17 2015-09-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services 19-norpregnadienodiona 17-alfa-sustituida, 11-beta-sustituida-4-arilo y 21-sustituida como agentes antiprogestacionales
HU227198B1 (en) 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
ES2212912B1 (es) * 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
CA2516319C (en) 2003-02-28 2012-09-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
GT200500186A (es) 2004-07-07 2006-03-02 Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits
CN1980660A (zh) * 2004-07-07 2007-06-13 惠氏公司 孕酮受体拮抗剂的避孕方案和试剂盒
BRPI0513141A (pt) 2004-07-09 2008-04-29 Population Council Inc composição para anel vaginal, e, processo de contracepção a longo prazo
EA200800974A1 (ru) 2005-09-29 2008-10-30 Репрос Терапьютикс Инк. Композиции с улучшенной биодоступностью, содержащие стероидное производное и полигликолизированный глицерид
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
JP5649305B2 (ja) * 2006-12-20 2015-01-07 テバ ウィメンズ ヘルス インコーポレイテッド プロゲスチンを含む口腔内崩壊性固体剤形ならびにその製造方法および使用方法
TW200831110A (en) 2006-12-28 2008-08-01 Repros Therapeutics Inc Methods and formulations for improved bioavailability of antiprogestins
JP5583976B2 (ja) * 2007-03-07 2014-09-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的プロゲステロン受容体モジュレーターとしてのステロイド誘導体
PE20090805A1 (es) * 2007-04-05 2009-07-25 Bayer Schering Pharma Ag COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL
JP2011507853A (ja) * 2007-12-20 2011-03-10 テバ ウィメンズ ヘルス インコーポレイテッド 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
RU2542779C2 (ru) 2009-04-14 2015-02-27 Лаборатуар Хра-Фарма Способ контрацепции, используемый по мере необходимости

Also Published As

Publication number Publication date
EP2419108A1 (en) 2012-02-22
ME02548B (me) 2017-02-20
US9616073B2 (en) 2017-04-11
CY1118236T1 (el) 2017-06-28
US20160317555A1 (en) 2016-11-03
RU2011146058A (ru) 2013-05-20
AU2010237120B8 (en) 2015-11-26
NZ615430A (en) 2014-06-27
JP5951480B2 (ja) 2016-07-13
EP3106167A1 (en) 2016-12-21
HUE029434T2 (en) 2017-02-28
RU2542779C2 (ru) 2015-02-27
AU2010237120B2 (en) 2015-10-22
PT2419108T (pt) 2016-11-07
SI2419108T1 (sl) 2017-02-28
JP2016188232A (ja) 2016-11-04
PL2419108T3 (pl) 2017-08-31
NZ595790A (en) 2013-11-29
HRP20161437T1 (hr) 2017-02-10
IL215524A0 (en) 2011-12-29
US10159681B2 (en) 2018-12-25
CA2757496A1 (en) 2010-10-21
BRPI1014035A2 (pt) 2016-04-12
RS55331B1 (sr) 2017-03-31
JP2012523446A (ja) 2012-10-04
ZA201107543B (en) 2012-06-27
SMT201600399B (it) 2017-01-10
HK1232150A1 (zh) 2018-01-05
CN102395373A (zh) 2012-03-28
US20150174140A1 (en) 2015-06-25
AU2010237120A1 (en) 2011-11-03
US20190209583A1 (en) 2019-07-11
ES2602134T3 (es) 2017-02-17
DK2419108T3 (en) 2016-12-05
US20120122828A1 (en) 2012-05-17
EP2419108B1 (en) 2016-08-17
US9283233B2 (en) 2016-03-15
WO2010119029A1 (en) 2010-10-21
US10772897B2 (en) 2020-09-15

Similar Documents

Publication Publication Date Title
HK1232150A1 (zh) 按需避孕方法
ZA202006532B (en) Method for decreasing immunogenicity
GB0905140D0 (en) Method
GB0911905D0 (en) Method
GB0902476D0 (en) Method
GB0910707D0 (en) Method
GB0913525D0 (en) Method
EP2474560A4 (en) METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE
GB0913433D0 (en) Method
GB0901444D0 (en) Method
PL2440510T3 (pl) Sposób wytwarzania pentafluoropropanu
IL214287A0 (en) Method for producing 2-aminobiphenylene
GB0905367D0 (en) Method
GB0903316D0 (en) Method
GB0908770D0 (en) Method
PL2446196T3 (pl) Sposób dostarczania ciepła
GB0916013D0 (en) Method
GB0902034D0 (en) Method
GB0900560D0 (en) Method
EP2420492A4 (en) PROCESS FOR PREPARING 2-HALOGEN-6-SUBSTITUTED 4-TRIFLUOROMETHYLPYRIDINE
GB0904946D0 (en) Method
GB0914702D0 (en) Method
GB0911362D0 (en) Method
GB0908816D0 (en) Method
GB0911717D0 (en) Method